NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Congratulations Sentiment!

Date:September 24,2018

44 already had lived to 36 months
29 methylated should live to 36 months
18 unmethylated should live to 36 months

approx. 91 total patients should live to 36 months or 27% of the trial’s enrollment.

That seems pretty extraordinary given that includes both treatment and control patients.(Sentiment)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143768358

That was a very good prediction Sentiment!!

Data set 2018: Survival at 3 years = 28.2%
Approx. 93 patients should live to 36 months of the trial’s enrollment.

44 already have lived to 36 months at the time of the analysis March 2017.
93-44=49 of the 69 patients alive between 18 months and 36 months at the time of the analysis March 2017 lived at least 36 months at the time of the analysis Nov 2018.
These figures give us a good indication of a slowing death rate.
Remember 2/month during the period March - August 2017!